|  | Trial period | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
 | Enrolment | Allocation | Intervention period | Follow up | Close out | |||||
 | May 2014– November 2016 | May 2014– November 2016 | Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | Week 6 | Week 6 | August 2014 – Feb 2017 |
Enrolment | ||||||||||
 Eligibility screening | X |  |  |  |  |  |  |  |  |  |
 Informed Consent | X |  |  |  |  |  |  |  |  |  |
 Allocation |  | X |  |  |  |  |  |  |  |  |
Intervention | ||||||||||
 Foot orthoses |  |  | X | X | X | X | X | X |  |  |
 Hip exercises |  |  | X | X | X | X |  |  |  |  |
Assessment | ||||||||||
 Diagnosis | X |  |  |  |  |  |  |  |  |  |
 Midfoot width mobility | X |  |  |  |  |  |  |  |  |  |
 Demographics |  | X |  |  |  |  |  |  |  |  |
 Global rating of change |  |  |  |  |  |  |  |  | X | X |
 Rate of recovery |  |  |  |  |  |  |  |  | X | X |
 Patient acceptable symptom state |  |  |  |  |  |  |  |  | X | X |
 Numerical pain rating |  | X |  |  |  |  |  |  | X | X |
 PSFS |  | X |  |  |  |  |  |  | X | X |
 Kujala |  | X |  |  |  |  |  |  | X | X |
 KOOS |  | X |  |  |  |  |  |  | X | X |
 HADS |  | X |  |  |  |  |  |  | X | X |
 Euro-QoL |  | X |  |  |  |  |  |  | X | X |
 TSK |  | X |  |  |  |  |  |  | X | X |
 PCS |  | X |  |  |  |  |  |  | X | X |
 Functional tests: step up, step down, squat |  | X |  |  |  |  |  |  | X | X |
 Navicular height |  | X |  |  |  |  |  |  |  | X |
 Midfoot height mobility |  | X |  |  |  |  |  |  |  | X |
 Isometric hip strength testing |  | X |  |  |  |  |  |  | X | X |
 Range of motion measures |  | X |  |  |  |  |  |  | X | X |